A specially designed fiber supplement may offer people with irritable bowel syndrome a way to support beneficial gut bacteria without aggravating the digestive symptoms that often make dietary changes difficult.
Researchers at Edith Cowan University’s Nutrition and Health Innovation Research Institute developed and tested a fiber combination called ur gut®. According to the university’s summary of the work, the blend improved gut health in people with IBS without increasing abdominal pain, bloating, diarrhea or constipation. It also improved gut-related anxiety and produced rapid changes in gut bacteria.
Addressing a difficult dietary trade-off
IBS is a common condition associated with digestive symptoms that can be disruptive and unpredictable. The source notes that its precise cause remains unclear, while stress, infections, some medicines, food choices, sleep, hormonal changes and lifestyle factors may all contribute to symptoms or make them worse.
Many people with IBS are advised to follow a low-FODMAP diet. This approach limits certain carbohydrates that are readily fermented by gut bacteria and can help control symptoms. But the source highlights an important tension: restricting those foods can also reduce fiber intake and beneficial gut bacteria over time.
That trade-off helps explain why a fiber intervention designed specifically for people with IBS could matter. A general instruction to consume more fiber is not necessarily simple for someone whose digestive symptoms can be sensitive to dietary changes. The goal described by the researchers was to support a healthier microbiome while allowing people to continue managing symptoms through a low-FODMAP diet.
Two familiar ingredients, used as a targeted blend
The supplement combines resistant starch with psyllium husk. The research summary attributes the promising results to that pairing. Resistant starch is intended to support beneficial gut bacteria, while psyllium is included in the formulation described by the researchers.
The result reported in the source is notable because the intervention was associated with improved gut-health measures without the rise in pain, bloating, diarrhea or constipation that can discourage people with IBS from trying new fiber products. The study summary also points to changes in gut bacteria that appeared quickly, suggesting the blend may influence the microbiome on a relatively short timescale.
Gut-related anxiety also improved in the tested group, according to the report. That finding is relevant because IBS is not experienced solely as a laboratory or dietary issue: concerns about symptoms can shape everyday choices around meals, travel, work and social activity.
What the findings do—and do not—establish
The results make the supplement a promising candidate for further work, rather than a universal solution for IBS. The supplied source describes a tested fiber combination and its reported outcomes, but it does not provide enough detail here to establish how the product compares with every other dietary strategy, how long benefits persist, or which groups of patients are most likely to respond.
Still, the study addresses a practical problem in IBS care. A low-FODMAP diet can reduce uncomfortable symptoms, yet long-term restriction may have consequences for fiber intake and beneficial bacteria. A formulation that can be used alongside symptom management, without worsening common symptoms in the study population, could give clinicians and patients another option to investigate.
A microbiome-focused direction for IBS research
The broader significance is the attempt to make symptom management and microbiome support compatible rather than competing goals. Instead of treating digestive comfort and beneficial bacterial activity as separate objectives, the research tests whether both can move in a favorable direction at once.
For now, the most supportable conclusion is measured: Edith Cowan University researchers report encouraging results for a resistant-starch and psyllium fiber blend in people with IBS. The blend was associated with improved gut-health measures, no worsening of the listed digestive symptoms, improved gut-related anxiety and rapid changes in gut bacteria. Further research will be needed to clarify how broadly those results apply and how the approach fits into longer-term IBS care.
This article is based on reporting by Science Daily. Read the original article.
Originally published on sciencedaily.com
